has Server used IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2012-11-21 (8 years, 308 days) and hosted in Dover United States, server ping response time 12 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Clozapinerems keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Clozapine rems
2 Clozapine rems login
3 Clozapine rems reversal
4 Clozapine rems program login
6 login
7 Clozapine rems program
8 Clozapine rems pdf
9 Clozapine rems ben

Hosting Provider

Region: DE
City: Dover
Postal Code: 19901
Latitude: 39.158798217773
Longitude: -75.494102478027
Area Code: 302
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain

New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » (13 hours ago)

   » (2 day ago)

   » (17 hours ago)

   » (1 day ago)

   » (14 day ago)

   » (2 day ago)

Results For Websites Listing

Found 48 Websites with content related to this domain, It is result after search with search engine

Clozapine REMS   DA: 17 PA: 23 MOZ Rank: 40

  • A REMS is a strategy to manage known or potential risks associated with a drug or group of drugs, and is required by the Food and Drug Administration (FDA) for clozapine to ensure that the benefits of the drug outweigh the risk of severe neutropenia
  • The Clozapine REMS Program replaces the individual clozapine patient registries and the

Clozapine REMS   DA: 24 PA: 24 MOZ Rank: 49

  • The Clozapine REMS (Risk Evaluation and Mitigation Strategy) is a safety program required by the Food and Drug Administration (FDA) to manage the risk of severe neutropenia associated with clozapine treatment
  • Severe neutropenia (absolute neutrophil count (ANC) less than 500/µL), can lead to serious and fatal infections.

Frequently Asked Questions Clozapine REMS …   DA: 11 PA: 50 MOZ Rank: 63

  • The modified Clozapine REMS Program will launch on November 15, 2021
  • Beginning August 2, 2021, stakeholders may contact the Clozapine REMS Transition Contact Center at 1-888-586-0758 for general

Clozapine REMS   DA: 24 PA: 23 MOZ Rank: 50

  • Enroll in the Clozapine REMS by completing the Prescriber Enrollment Form and submitting it to the Clozapine REMS
  • Clozapine and the Risk of Neutropenia: A Guide for Healthcare Providers
  • Knowledge Assessment for Prescribers

Clozapine REMS Requirements Will Change On …   DA: 11 PA: 50 MOZ Rank: 65

For additional information about the Clozapine REMS Program, please call the Clozapine REMS Program Contact Center at 844-267-8678 or visit

Clozapine REMS Program   DA: 18 PA: 46 MOZ Rank: 69

  • A Treatment Rationale can be submitted by logging into your account at or by calling the Clozapine REMS Program Contact Center at 844-267-8678
  • If a patient does not have an ANC on file with the REMS, a dispense will not be authorized.

Clozapine: Generic, Uses, Side Effects, Dosages   DA: 14 PA: 48 MOZ Rank: 68

  • Available only through a restricted program called the Clozapine REMS; Severe neutropenia, defined as an absolute neutrophil count (ANC) less than 500/mm³, has been reported; Severe neutropenia can lead to serious infection and death; Prior to initiating treatment, a baseline ANC must be 1500/mm³ or greater for the general population and 1000/mm³ or …   DA: 21 PA: 19 MOZ Rank: 47

  • Clozapine REMS requirements will change on November … Jul 29, 2021 · For additional information about the Clozapine REMS Program, please call the Clozapine REMS Program Contact Center at 844-267-8678 or visit


  • The Clozapine REMS Program (CRP) is an FDA-mandated program implemented by the manufacturers of clozapine to provide a centralized point of access for pharmacists and prescribers to minimize the risk of clozapine-associated neutropenia
  • Prescribers, pharmacies and patients must be enrolled with

Approved Risk Evaluation And Mitigation Strategies …   DA: 22 PA: 28 MOZ Rank: 59

  • The goal of the Clozapine REMS Program is to mitigate the risk of severe neutropenia associated with the use of clozapine by: Educating prescribers and pharmacists about the risk of severe neutropenia and appropriate monitoring requirements
  • Informing patients about the risk of severe neutropenia and appropriate monitoring requirements.

Changes To The Clozapine REMS Will Take Effect On …   DA: 26 PA: 50 MOZ Rank: 86

  • Changes to the Clozapine REMS will Take Effect on November 15, 2021 – Be Prepared
  • Clozapine was one of the first drugs to have a “REMS” system in place to ensure safe use such that patients developing clozapine-induced severe neutropenia were precluded from getting the drug, which would do further damage, and, thus, avoiding potentially

Clozapine Dosage Guide + Max Dose, Adjustments   DA: 13 PA: 22 MOZ Rank: 46

  • -Patients should be informed of the significant risk of developing agranulocytosis and that their participation in the CLOZAPINE REMS Program is designed to reduce this risk; patients will need to immediately report symptoms consistent with severe neutropenia or infection (e.g
  • fever, weakness, lethargy, or sore throat).

Update: New Clozapine REMS Coming November 15, …   DA: 26 PA: 50 MOZ Rank: 88

  • The modification to Clozapine REMS will go into effect on November 15, 2021
  • Important changes include: All prescribers and pharmacies must be re-certified by November 15, 2021, or they will no longer be able to prescribe/dispense clozapine
  • Prescribers must re-enroll their patients who will continue clozapine by November 15, 2021.


  • Prescribers, pharmacies and patients must be enrolled with the Clozapine REMS Program
  • Further information is available at or 1-844-267-8678
  • For additional safety information, please see full Prescribing Information , including Boxed Warning.

FDA Updates Clozapine REMS Program   DA: 22 PA: 40 MOZ Rank: 76

  • The FDA has modified the Clozapine Risk Evaluation and Mitigation Strategy (REMS)
  • Starting November 15, 2021, pharmacies that dispense clozapine will now need to obtain a pre-dispense authorization that can be accessed on the Clozapine REMS website ( or the Clozapine REMS Contact Center (888-586-0758).They will no longer be able to use the current …

Clozaril (clozapine) For Schizophrenia: Uses, Dosage, …   DA: 14 PA: 18 MOZ Rank: 47

  • Further information is available at or 1-844-267-8678
  • Orthostatic Hypotension, Bradycardia, And Syncope
  • Hypotension, bradycardia, syncope, and cardiac arrest have occurred with clozapine treatment
  • The risk is highest during the initial titration period, particularly with rapid dose-escalation.

Versacloz® (clozapine, USP) Information For Healthcare   DA: 13 PA: 13 MOZ Rank: 42

  • Versacloz is indicated for: Treatment-resistant schizophrenia in severely ill patients
  • Because of the significant risk of agranulocytosis and seizure associated with its use, VERSACLOZ should be used only in patients who have failed to respond adequately to standard antipsychotic treatment
  • The effectiveness of clozapine was established in a 6

Management Of Clozapine Treatment During The COVID …   DA: 23 PA: 10 MOZ Rank: 50

  • Clozapine is the only available treatment for refractory schizophrenia but its use involves frequent physical contact with healthcare workers for the purpose of mandatory blood monitoring
  • During the COVID-19 pandemic, patients taking clozapine will be self-isolating to reduce the risk of infection, …

Updated Clozapine REMS Program Requires …   DA: 30 PA: 30 MOZ Rank: 78

  • Clozapine REMS Program Resources
  • APA has posted online information about the Clozapine REMS Program for prescribers here
  • APA also administers the SMI Adviser Clozapine Center of Excellence listserv, which provides updates on new resources, education, and other information related to clozapine
  • The sign-up link is located here


  • Because of the risk of severe neutropenia, clozapine is available only through a restricted program called the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program
  • This program is designed to ensure you have the required blood tests before filling your prescription
  • Prescribers, patients, and pharmacies must

What Is Clozapine REMS   DA: 14 PA: 38 MOZ Rank: 72

  • The Clozapine REMS Program focuses on patient monitoring for and management of clozapine-induced severe neutropenia, providing a centralized system for prescribers and pharmacists to manage patient risk: or 844-267-8678
  • Changes were made to the REMS system effective February 28, 2019.

Important Clozapine REMS Program Changes …   DA: 12 PA: 50 MOZ Rank: 83

According to the Agency, the Clozapine REMS program will include the following important modifications: Prescribers and pharmacies must be re-certified in …

New Changes To Clozapine REMS Program Require   DA: 21 PA: 39 MOZ Rank: 82

  • New changes to clozapine REMS program require certification
  • On February 28, changes to the clozapine Risk Evaluation and Mitigation Strategy (REMS) program went into effect that focus on ensuring patients have continued access to the drug and …

Rediscovering Clozapine: After A Turbulent History   DA: 14 PA: 50 MOZ Rank: 87

  • The clozapine REMS program Six clozapine registries operated independently, each managed by a different manufacturer, 10 until the FDA introduced REMS in September 2015
  • The REMS program created a centralized registry to monitor all U.S
  • patients treated with clozapine and made important changes to prescribing and monitoring guidelines

Clozapine Success Stories CURESZ Foundation   DA: 10 PA: 27 MOZ Rank: 61

  • Bethany Yeiser, President, CURESZ Foundation CURESZ “Schizophrenia Survivors” are people who are thriving despite a past diagnosis of schizophrenia, and live lives of meaning and purpose
  • Ravi, Lucas and myself have recovered from schizophrenia on the rarely used medication clozapine
  • We also feature Eric Smith here who recovered from severe bipolar disorder on

First IPLEDGE, Now Clozapine REMS Changes NCPA   DA: 8 PA: 50 MOZ Rank: 83

  • In July we told you about the changes to the isotretinoin Risk Evaluation and Mitigation Strategy
  • Now we have an update on changes for the clozapine REMS
  • 16, pharmacies need to re-certify and re-enroll staff members to avoid interruption in patient treatment
  • Pharmacies must be certified in the Clozapine REMS Program in order to purchase and dispense clozapine.


  • The Clozapine REMS Program can be accessed at: or by calling 1-844-267-8678
  • Prior to dispensing clozapine, pharmacies must verify ANC is current and acceptable for each patient or verify the prescriber has authorized

Quick Reference Guide For Prescribing/Ordering …   DA: 10 PA: 50 MOZ Rank: 87

  • patient’s clozapine REMS monitoring frequency
  • Although such orders may be processed with a manual pharmacy review of the stop date(s) in the pharmacy package, it is recommended that prescribers avoid the use of complex inpatient medication orders for clozapine until the software issues are resolved

Clozapine In Practice: A Toolkit   DA: 8 PA: 25 MOZ Rank: 61

  • Clozapine in Practice: A Toolkit
  • Clozapine is the medication of choice for those with treatment-resistant schizophrenia
  • Clozapine is also FDA approved for the reduction in suicidal behavior in schizophrenia or schizoaffective disorder and effective for treatment-resistant mood disorders
  • Despite the clinical benefits of clozapine, hesitancy

Clozapine Adult Dosing   DA: 20 PA: 20 MOZ Rank: 69

[1-844-267-8678 or for more info] schizophrenia, tx-resistant [150-300 mg PO bid]

Clozapine Prices, Coupons & Savings Tips   DA: 14 PA: 10 MOZ Rank: 54

  • Compare prices, print coupons and get savings tips for Clozapine (Generic Clozaril and Fazaclo) and other Schizophrenia drugs at CVS, Walgreens, and other pharmacies

Guidelines For Prescribing Clozapine In Schizophrenia   DA: 16 PA: 50 MOZ Rank: 97

  • A clozapine plasma level in the range of 250 to 350 ng/mL is a reasonable target for a patient with schizophrenia
  • However, patients show great variation in both their symptomatic response and side effects and the target plasma level should be individualized based on these outcomes.

Clozapine (Clozaril/FazaClo) NAMI: National Alliance …   DA: 12 PA: 50 MOZ Rank: 94

  • Clozapine is a medication that works in the brain to treat schizophrenia
  • It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic. Clozapine rebalances dopamine and serotonin to improve thinking, mood, and behavior
  • Symptoms of schizophrenia include:

Clozapine REMS FAQ Updated By REMS Personnel …   DA: 8 PA: 27 MOZ Rank: 68

The ClozapineREMS has reviewed and updated content available in CPNP's Clozapine FAQ document.CPNP has had dialogue with the American Psychiatric Association and the American Association of Community Psychiatry both of which have shared similar concerns with some of the ClozapineREMS requirements.

COVID-19 #9 – Focus Groups Service Changes …   DA: 25 PA: 50 MOZ Rank: 16

  • Clozapine REMS During COVID-19; FDA Issues Statement on REMS During COVID-19 Partners wishes to share the following information with you regarding patients who are receiving clozapine treatment, which entails following an FDA mandated REMS due to risk of neutropenia
  • The FDA has released a statement for providers to consider during this time.

CLOZAPINE Flashcards   DA: 11 PA: 33 MOZ Rank: 79

  • ANC must be submitted to the clozapine REMS program withing 15 days • Predispense Authorization (PDA) An authorization given to outpatient pharmacies which relects that the safe-use conditions for that patient have been met

Seizure Associated With Clozapine: Incidence, Etiology   DA: 23 PA: 10 MOZ Rank: 69

  • Seizures are a known adverse effect of clozapine therapy
  • The literature varies on incidence rates of seizures, secondary to varying time frames in which each seizure occurred
  • Tonic-clonic seizures comprise the majority of seizures experienced secondary to clozapine use, but it is imperative to rec …

Recently Analyzed Sites (13 hours ago) (2 day ago) (17 hours ago) (1 day ago) (14 day ago) (12 hours ago) (5 day ago) (14 seconds ago) (3 day ago) (4 day ago) (3 day ago) (6 day ago)